Access and Evidence
Merck Patent the Latest Casualty in India's Branded Drugs War
India has revoked yet another drug company's patent, this time for an asthma drug patented by Schering Corp, later bought by Merck
More Access and Evidence Articles
Access and Evidence
Streamlining Key Services Your Drug Delivery Device Partners Provide
With advanced drug delivery systems like auto injectors and pen injectors becoming an emerging trend for the pharmaceutical industry, such combination products will require close collaboration between the pharma and the device manufacturers.
Access and Evidence
Real World Data: A Bigger Piece of the Pharma Picture
Experts and analysts worldwide are increasingly citing the advantages of shifting data collection methods in the pharma industry to yield research-based evidence.
Access and Evidence
Pfizer’s One of a Kind Genetic Lung Cancer Therapy Receives EU Conditional Approval
Pfizer’s recent lung cancer therapy targeting a specific genetic protein is the first personalized treatment of its kind to be approved by Europe.
Access and Evidence
New US Public-Private Partnership Set to Transform Medical Device Industry
By reducing costs and time to launch products on the market, a US Food and Drug Administration (FDA) initiative is set to change the face of the medical device manufacturing and marketing.
Access and Evidence
Merck Serono Initiates First Multinational Partnership for Branded Drugs in the UAE
A distinctive partnership between Merck Serono and an Abu Dhabi manufacturer is the first of its kind that will develop branded drugs for the UAE.
Access and Evidence
NICE Against NHS Funding of Pirfenidone in Pulmonary Fibrosis
National Institute for Health and Clinical Excellence issued preliminary guidelines against prescribing pirfenidone (Esbriet) to patients with idiopathic pulmonary fibrosis.
Access and Evidence
Real World Evidence Shows Antiretroviral Treatment Reduces HIV Transmission
A “real world” HIV drug study in China has confirmed the value that antiretroviral (ARV) pharmaceuticals offer HIV-positive patients and their uninfected partners.
Access and Evidence
EMA Will Form Advisory Groups Over Clinical Trial Transparency
The European Medicines Agency is planning to form advisory groups to look into ongoing issues of access to clinical trial data.
Access and Evidence
We Need An International Solution for Publishing Clinical Trials
Despite several guidelines stating the need to publish all trial information, an extensive amount of negative data still remains hidden.